Bruce McCall
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
- Otorhinolaryngology top 10%
Papers in
- Oncology 12
- Colorectal Cancer Treatments and Studies 5
- HER2/EGFR in Cancer Research 4
- CAR-T cell therapy research 4
- Peptidase Inhibition and Analysis 3
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Maria Anderson (5 shared papers)Andrea Pirzkall (4 shared papers)Amy V. Kapp (4 shared papers)Elicia Penuel (3 shared papers)Antonio Jimeno (2 shared papers)Lori J. Wirth (2 shared papers)Ina Rhee (4 shared papers)Chi‐Chung Li (4 shared papers)
- Journals
- The Oncologist (3 papers)Blood (3 papers)Journal of Clinical Oncology (2 papers)American Journal of Nephrology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- United StatesSpainAustralia
In The Last Decade
Bruce McCall
13 papers receiving 368 citations
Peers
Comparison fields: 5 of 44
- Oncology 276
- Otorhinolaryngology 26
- Immunology 95
- Radiology, Nuclear Medicine and Imaging 95
- Pulmonary and Respiratory Medicine 103
Countries citing papers authored by Bruce McCall
This map shows the geographic impact of Bruce McCall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce McCall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce McCall more than expected).
Fields of papers citing papers by Bruce McCall
This network shows the impact of papers produced by Bruce McCall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce McCall. The network helps show where Bruce McCall may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruce McCall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 84 | |
| 2 | 2016 | 55 | |
| 3 | 2018 | 44 | |
| 4 | 2016 | 36 | |
| 5 | 2014 | 35 | |
| 6 | 2013 | 26 | |
| 7 | 2017 | 25 | |
| 8 | 2017 | 23 | |
| 9 | 2018 | 19 | |
| 10 | 2018 | 15 | |
| 11 | 2021 | 5 | |
| 12 | 2015 | 5 | |
| 13 | 2019 | 3 | |
| 14 | 1990 | 1 |
About Bruce McCall
Bruce McCall is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 14 papers that have together received 376 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), HER2/EGFR in Cancer Research (4 papers), CAR-T cell therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Peptidase Inhibition and Analysis (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Gastric Cancer Management and Outcomes (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (276 citations), Otorhinolaryngology (26 citations), Immunology (95 citations), Radiology, Nuclear Medicine and Imaging (95 citations) and Pulmonary and Respiratory Medicine (103 citations). Bruce McCall has collaborated with scholars based in United States, Spain and Australia. Frequent co-authors include Maria Anderson, Andrea Pirzkall, Amy V. Kapp, Elicia Penuel, Antonio Jimeno, Lori J. Wirth, Ina Rhee, Chi‐Chung Li, Paul E. O’Brien and Jan B. Vermorken. Their work appears in journals such as The Oncologist, Blood, Journal of Clinical Oncology, American Journal of Nephrology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.